Jonatan Leffler
Paola Triggianese- 1Telethon Kids Institute, University of Western Australia, Perth, WA, Australia
- 2Rheumatology Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy
Editorial on the Research Topic
The relationship between puberty and immune-driven disease
The way the immune system operates differs between males and females. This is due to both differential expression of immune-related genes from the sex chromosomes as well as the immune modulatory properties of sex hormones. Together, these effects contribute to a skewed prevalence of disease and disease course between males and females, including allergic-, infectious-, autoimmune-, and cancerous disease (1, 2). The impact of sex hormones is evident across several disorders, including immune-driven pathologies such as asthma and multiple sclerosis (MS), which changes significantly in both prevalence and phenotype at the time of puberty (3, 4). As a result, puberty is a period where susceptibility to disease may dramatically change for an individual. It may also impact individuals with an already established disease who may face a transition in disease phenotype or severity, as demonstrated by this research topic. An established disease may also resolve at the time of puberty; a common example of this is allergic asthma, which decreases significantly in prevalence in males whilst the prevalence in females increases (3).
For this Research Topic we encouraged submission of studies on the topic of how immune-driven disease is influenced by puberty. We have included both original articles and reviews on disease that, after puberty, might be different in females and males, likely due to the effects of sex hormones (5).
Two reviews were included in this topic. One focused on the impact of puberty on autoimmune diseases in general and the impact of hormones on immune cells subsets, and another review focused specifically on the impact of puberty on MS. The first review by Yang et al. linked puberty to altered metabolism and levels of sex hormones, and evaluated how this modulated the immune system. This was related to pathogenesis of autoimmune conditions, such as systemic lupus erythematosus (SLE) and rheumatoid arthritis, of which some can have an early onset, even prior to puberty.
The second review by Ucciferri et al. focused specifically on the impact of puberty on MS. It highlighted the likely contribution of sex hormones to the development of pediatric MS through the observation that pre-puberty, the number of females with MS was the same as the number of males, whereas after puberty, MS was two to three times more common in females compared to males. The review also discussed the impact of BMI, puberty timing, and assisted reproductive techniques on the risk of developing MS. In addition, findings from animal models of MS, where the impact of puberty can be investigated in more detail, were also discussed and complemented with references to detailed immunological studies carried out in humans before and after puberty.
In addition to the reviews, our Research Topic also included original research focusing on the impact of puberty on defined autoimmune diseases such as thyroiditis as well as in the context of rare diseases related to abnormal complement system regulation, specifically hereditary angioedema due to C1-inhibitor deficiency (C1INH-HAE). The study by Kyristi et al. reported that in girls with premature puberty, a quarter of individuals also presented with autoimmune thyroiditis. From the study it was not clear if the premature puberty contributed to the autoimmune condition or if the thyroiditis instead contributed to premature puberty. A clear association with obesity and insulin resistance was interestingly observed. These findings illustrate that puberty may not only influence immune-driven disease, but puberty may be influenced by disease as well. The second study by Cancian et al. investigated the role of puberty on disease course and severity in Italian C1INH-HAE patients. Using questionnaires across centers in Italy, the study reported a significant increase in angioedema attacks following puberty, and that this worsening appeared more pronounced in females compared to males. The possible reason for this may be related to the impact of sex hormones since estrogens are well known to trigger angioedema attacks, which may also be important to consider during pregnancy (6).
Together these studies demonstrate the significant impact that puberty and sex hormones may have on immune-driven diseases. As these effects can both be positive and negative, this may provide an opportunity for novel and exciting therapeutic interventions aimed at modulating the immunological effects of sex hormones. Pilot studies of hormone supplementation in some autoimmune diseases have showed some promise as reviewed (7), but interventions using hormones may not be suitable for individuals of fertile age. Directly targeting the immune system may be a more appropriate strategy for such population. The immune modulatory effects of hormones are also relevant for transgender individuals who choose to take gender affirming hormone therapy to align their body with their gender. How exogenous sex hormones interact with male/female genes is an area where more immunology-focused research is required, as we have recently discussed (8).
In summary, puberty is a period of change in the mental and physiological aspects of an individual. As this research topic has also highlighted, significant changes also occur in the immune system, and these changes are important to consider when evaluating treatment strategies and clinical care for young individuals with immune-driven disease.
Author contributions
JL and PT wrote the manuscript and agreed to the submission. All authors contributed to the article and approved the submitted version.
Funding
JL is funded by a fellowship from the Western Australian Future Health and Research Innovation Fund. PT has no funding to declare.
Acknowledgments
The authors would like to acknowledge the contributors of this research topic.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1. Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. (2016) 16(10):626–38. doi: 10.1038/nri.2016.90
2. Triggianese P, Novelli L, Galdiero MR, Chimenti MS, Conigliaro P, Perricone R, et al. Immune checkpoint inhibitors-induced autoimmunity: the impact of gender. Autoimmun Rev. (2020) 19(8):102590. doi: 10.1016/j.autrev.2020.102590
3. Yung JA, Fuseini H, Newcomb DC. Hormones, sex, and asthma. Ann Allergy Asthma Immunol. (2018) 120(5):488–94. doi: 10.1016/j.anai.2018.01.016
4. Chitnis T. Role of puberty in multiple sclerosis risk and course. Clin Immunol. (2013) 149(2):192–200. doi: 10.1016/j.clim.2013.03.014
5. Leffler J, Trend S, Gorman S, Hart PH. Sex-Specific environmental impacts on initiation and progression of multiple sclerosis. Front Neurol. (2022) 13:835162. doi: 10.3389/fneur.2022.835162
6. Triggianese P, Senter R, Petraroli A, Zoli A, Lo Pizzo M, Bignardi D, et al. Pregnancy in women with hereditary angioedema due to C1-inhibitor deficiency: results from the ITACA cohort study on outcome of mothers and children with in utero exposure to plasma-derived C1-inhibitor. Front Med (Lausanne). (2022) 9:930403. doi: 10.3389/fmed.2022.930403
7. Moulton VR. Sex hormones in acquired immunity and autoimmune disease. Front Immunol. (2018) 9:2279. doi: 10.3389/fimmu.2018.02279
Keywords: autoimmunity, immune modulation, inflammation, puberty, sex hormones
Citation: Leffler J and Triggianese P (2023) Editorial: The relationship between puberty and immune-driven disease. Front. Pediatr. 11:1244240. doi: 10.3389/fped.2023.1244240
Received: 22 June 2023; Accepted: 27 June 2023;
Published: 6 July 2023.
Edited and Reviewed by: Erkan Demirkaya, Western University, Canada
© 2023 Leffler and Triggianese. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jonatan Leffler am9uYXRhbi5sZWZmbGVyQHRlbGV0aG9ua2lkcy5vcmcuYXU=